caa a22 4500 445311142 CHVBK 20180317142630.0 cr unu---uuuuu 170323e20110801xx s 000 0 eng 10.1007/s00404-011-1874-1 doi (NATIONALLICENCE)springer-10.1007/s00404-011-1874-1 Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT [Elektronische Daten] [Michael von Wolff, Markus Montag, Ralf Dittrich, Dominik Denschlag, Frank Nawroth, Barbara Lawrenz] Purpose: Fertility preservation methods are playing an increasing role in women up to the age of 40years because of rising survival rates in those affected by cancer. However, balanced practical recommendations concerning all relevant fertility preservation, to support doctors in counselling and treating patients, are still rare. Methods: These recommendations were prepared by the network FertiPROTEKT ( http://www.fertiprotect.eu ), a collaboration of around 70 centres in Germany, Switzerland and Austria. The recommendations were developed by specialists in reproductive medicine, reproductive biology and oncology, which gave a comprehensive overview of all named techniques as well as their benefits and risks. Furthermore, practice-orientated recommendations for the individual use of fertility preservation methods for various indications such as breast cancer, Hodgkin's lymphoma and borderline ovarian tumours are given. Results: Various options such as ovarian stimulation and cryopreservation of unfertilised or fertilised oocytes, cryopreservation and transplantation of ovarian tissue, GnRH-agonist administration and transposition of the ovaries can be offered. All the techniques can be performed alone or in combination within a maximum of 2weeks with low risk and different success rates. Conclusions: Fertility preservation in women has become an option with realistic chances to become pregnant after cytotoxic therapies. The information provided allows a well balanced and realistic counselling and treatment. The Author(s), 2011 Cancer nationallicence Fertility preservation nationallicence Oocytes nationallicence Ovarian tissue nationallicence Cryopreservation nationallicence GnRH agonists nationallicence von Wolff Michael Department of Gynaecological Endocrinology and Reproductive Medicine, University Women's Hospital, Effingerstrasse 102, 3010, Bern, Switzerland aut Montag Markus Department of Gynaecological Endocrinology and Reproductive Medicine, University Women's Hospital, Bonn, Germany aut Dittrich Ralf University Women's Hospital, Erlangen, Germany aut Denschlag Dominik Hochtaunus-Kliniken, Bad Homburg, Germany aut Nawroth Frank Hormon- und Pränatalzentrum, Hamburg, Germany aut Lawrenz Barbara University Women's Hospital, Tuebingen, Germany aut Archives of Gynecology and Obstetrics Springer-Verlag 284/2(2011-08-01), 427-435 0932-0067 284:2<427 2011 284 404 https://doi.org/10.1007/s00404-011-1874-1 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s00404-011-1874-1 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- von Wolff Michael Department of Gynaecological Endocrinology and Reproductive Medicine, University Women's Hospital, Effingerstrasse 102, 3010, Bern, Switzerland aut NATIONALLICENCE 700 1- Montag Markus Department of Gynaecological Endocrinology and Reproductive Medicine, University Women's Hospital, Bonn, Germany aut NATIONALLICENCE 700 1- Dittrich Ralf University Women's Hospital, Erlangen, Germany aut NATIONALLICENCE 700 1- Denschlag Dominik Hochtaunus-Kliniken, Bad Homburg, Germany aut NATIONALLICENCE 700 1- Nawroth Frank Hormon- und Pränatalzentrum, Hamburg, Germany aut NATIONALLICENCE 700 1- Lawrenz Barbara University Women's Hospital, Tuebingen, Germany aut NATIONALLICENCE 773 0- Archives of Gynecology and Obstetrics Springer-Verlag 284/2(2011-08-01), 427-435 0932-0067 284:2<427 2011 284 404 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer